colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) According to the above diagnostic criteria, stage III colorectal cancer was diagnosed; (2) They agreed to accept radical operation, and were clinically diagnosed as tn1-2m0 after consultation, physical examination, laboratory examination and imaging examination; (3) Agree to collect colorectal cancer tissue samples, and agreed to carry out pathological test, MMR, RAS, malta1, NF2 gene detection and Merlin protein expression; (4) We agreed to collect peripheral blood for metabonomics analysis; (5) Aged >=18 years old; (6) The ECoG of the patients with an estimated survival time of more than 6 months was less than 2; (7) They agreed to be followed up; (8) The follow-up and clinical data were complete; (9) Those who voluntarily sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Complicated with other primary malignant tumor; (2) Complicated with serious heart, brain, liver, kidney disease, electrolyte abnormality or mental illness; (3) Patients who are allergic to the drugs used in this study or their ingredients; (4) Pregnancy, lactation or planned pregnancy; (5) With serious or uncontrollable infections; (6) Those who took other traditional Chinese medicine or participated in other clinical trials in recent 2 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| OS;Safety-related physical and chemical indicators;TCM symptom score scale;Quality of life scale; | — |
Countries
China
Contacts
Shanghai Municipal Hospital of Traditional Chinese Medicine